BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15606388)

  • 1. Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis.
    Fabrizi F; Martin P; Dixit V; Bunnapradist S; Dulai G
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1271-7. PubMed ID: 15606388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies.
    Fabrizi F; Takkouche B; Lunghi G; Dixit V; Messa P; Martin P
    J Viral Hepat; 2007 Oct; 14(10):697-703. PubMed ID: 17875004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus and mortality among patients on dialysis: A systematic review and meta-analysis.
    Fabrizi F; Dixit V; Messa P
    Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):244-254. PubMed ID: 30910601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality?
    Fabrizi F; Dixit V; Messa P
    J Viral Hepat; 2012 Sep; 19(9):601-7. PubMed ID: 22863263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C and Its Metabolic Complications in Kidney Disease.
    Fabrizi F; Donato FM; Messa P
    Ann Hepatol; 2017 November-December,; 16(6):851-861. PubMed ID: 29055921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C-related liver disease in dialysis patients.
    Fabrizi F; Dixit V; Messa P; Martin P
    Contrib Nephrol; 2012; 176():42-53. PubMed ID: 22310780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival advantage of kidney transplantation over dialysis in patients with hepatitis C: a systematic review and meta-analysis.
    Ingsathit A; Kamanamool N; Thakkinstian A; Sumethkul V
    Transplantation; 2013 Apr; 95(7):943-8. PubMed ID: 23425817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of hepatitis C virus infection on long-term outcome in renal transplant patients.
    Ruhı Ç; Süleymanlar İ; Koçak H; Yilmaz VT; Çolak D; Dınçkan A; Gürkan A; Ersoy F; Yakupoğlu G; Süleymanlar G
    Turk J Gastroenterol; 2011; 22(2):165-70. PubMed ID: 21796553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of death among chronic dialysis patients infected with hepatitis C virus.
    Stehman-Breen CO; Emerson S; Gretch D; Johnson RJ
    Am J Kidney Dis; 1998 Oct; 32(4):629-34. PubMed ID: 9774125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon monotherapy of chronic hepatitis C in dialysis patients: meta-analysis of clinical trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    J Viral Hepat; 2008 Feb; 15(2):79-88. PubMed ID: 18184190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis: the dialysis mode and immunological response to hepatitis B virus vaccine in dialysis population.
    Fabrizi F; Dixit V; Bunnapradist S; Martin P
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1105-12. PubMed ID: 16611270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pretransplant chronic hepatitis C virus infection treatment on graft and patient survival in renal transplant recipients.
    Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Ensaroğlu F; Selçuk H; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():188-92. PubMed ID: 25894152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies.
    Fabrizi F; Martin P; Dixit V; Bunnapradist S; Dulai G
    Am J Transplant; 2005 Jun; 5(6):1452-61. PubMed ID: 15888054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease.
    Fabrizi F; Martin P; Dixit V; Bunnapradist S; Dulai G
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1053-62. PubMed ID: 15569107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group.
    Pereira BJ; Natov SN; Bouthot BA; Murthy BV; Ruthazer R; Schmid CH; Levey AS
    Kidney Int; 1998 May; 53(5):1374-81. PubMed ID: 9573555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus and the immunological response to hepatitis B virus vaccine in dialysis patients: meta-analysis of clinical studies.
    Fabrizi F; Dixit V; Martin P; Messa P
    J Viral Hepat; 2011 Dec; 18(12):871-6. PubMed ID: 22093033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in dialysis patients with HCV infection.
    Fabrizi F; Messa P; Martin P
    Int J Artif Organs; 2009 Aug; 32(8):473-81. PubMed ID: 19844890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis: the impact of diabetes mellitus on the immunological response to hepatitis B virus vaccine in dialysis patients.
    Fabrizi F; Dixit V; Martin P; Messa P
    Aliment Pharmacol Ther; 2011 Apr; 33(7):815-21. PubMed ID: 21281319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus genotype does not affect patient survival among renal transplant candidates. The New England Organ Bank Hepatitis C Study Group.
    Natov SN; Lau JY; Ruthazer R; Schmid CH; Levey AS; Pereira BJ
    Kidney Int; 1999 Aug; 56(2):700-6. PubMed ID: 10432411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.